Tumor complement fraction recovery method and product

Details Tumor complement fraction recovery method and product Tumor complement fraction recovery method and product

1975-07-29

1978-02-28

Michl, Paul R.

Chemistry of carbon compounds

Miscellaneous organic carbon compounds

C-metal

232585R, 210DIG23, A23J 106

Patent

active

040767019

ABSTRACT:
A process is provided for the isolation of a blood polypeptide fraction or derivatives thereof herein termed the "tumor complement fraction" or "TCF", from mammalian blood. The process comprises a series of centrifugal separations of blood fractions under conditions which maintain the integrity of the desired material as it existed in vivo.
The Tumor Complement Fraction, is a new material and it constitutes another aspect of the disclosure. Isolated TCF, a natural polypeptide or derivative thereof, is useful as a neoplastic tissue remission and prevention agent.

REFERENCES:
patent: 3657116 (1972-04-01), Haller
patent: 3823126 (1974-07-01), Bjorklund

Affiliated with

Also associated with

Rating

Tumor complement fraction recovery method and product does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor complement fraction recovery method and product, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor complement fraction recovery method and product will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1675625